Document Detail


Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube.
MedLine Citation:
PMID:  15990258     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients in intensive care often develop stress-induced ulcers. As a preventive measure, proton pump inhibitors (PPIs) are administered by nasogastric tube. However, some PPIs can block the tube. The aim of this study was to compare the behaviour of three PPIs (omeprazole, lanzoprazole and esomeprazole) during the transit of the granules through the tube and to optimise their modes of administration. For each IPP, the experiment was designed to study the influence of four variables: the tube material (silicone or polyurethane), the solvent used to dilute the granules (water or apple juice), the mode of administration (in two or three doses) and the rinse volume (10 or 20 ml). We counted the granules before transit and at the tube outlet, and assayed the active drug ingredient by UV spectrometry. The assay showed complete transit of esomeprazole through the tube, but average losses of omeprazole and lanzoprazole of 39 and 33%, respectively, were observed. No significant improvement was obtained by the variables 'diluent' and 'mode of administration'. The variable 'rinse' had a significant influence. For lanzoprazole, a polyurethane tube allowed recovery of on average 86% of the active ingredient. Esomeprazole is thus the choice PPI for the treatment of patients by nasogastric tube. Using a polyurethane tube and a rinse volume of 20 ml, the administration of lanzoprazole by tube can be considered. Use of omeprazole is not recommended because none of the modes of administration tested ensured that a sufficient concentration of active ingredient reached the stomach.
Authors:
D Messaouik; V Sautou-Miranda; S Bagel-Boithias; J Chopineau
Related Documents :
12751128 - Isolated bundle branch block and left ventricular dysfunction.
1148068 - Advanced heart block aggravated by carbamazepine.
11999098 - Transient complete heart block complicating acute rheumatic fever.
15635198 - Clinical implications of intermediate qrs prolongation in the absence of bundle-branch ...
16565558 - Early positive biomarker in relation to myocardial necrosis and impaired fatty acid met...
1721148 - Successful catheter fulguration of the his bundle in a postoperative mustard patient af...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  International journal of pharmaceutics     Volume:  299     ISSN:  0378-5173     ISO Abbreviation:  Int J Pharm     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-18     Completed Date:  2006-02-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7804127     Medline TA:  Int J Pharm     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  65-72     Citation Subset:  IM    
Affiliation:
Service Pharmacie, Hôpital G. Montpied, Rue Montalembert, BP69, 63003 Clermont-Ferrand, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Ulcer Agents / chemistry*
Beverages
Intubation, Gastrointestinal / methods*
Malus
Omeprazole / analogs & derivatives,  chemistry
Particle Size
Polyurethanes
Proton Pumps / antagonists & inhibitors*
Rheology
Silicones
Solvents
Water
Chemical
Reg. No./Substance:
0/2-Pyridinylmethylsulfinylbenzimidazoles; 0/Anti-Ulcer Agents; 0/Polyurethanes; 0/Proton Pumps; 0/Silicones; 0/Solvents; 103577-45-3/lansoprazole; 73590-58-6/Omeprazole; 7732-18-5/Water

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and hom...
Next Document:  Antioxidant activity of Aporosa lindleyana root.